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resistant to neurodegeneration (WldS and Sarm1−/−), 
we found that the three different fibrils were secreted by 
axons after anterograde transport, in the absence of axonal 
lysis, indicating that trans-neuronal spread can occur in 
intact healthy neurons. In summary, fibrils of α-synuclein, 
Aβ42 and HTTExon1 are all transported in axons but in 
directions and amounts that are specific of each fibril. After 
anterograde transport, the three fibrils were secreted in the 
medium in the absence of axon lysis. Continuous secre-
tion could play an important role in the spread of pathology 
between neurons but may be amenable to pharmacological 
intervention.
Keywords α-Synuclein · Aβ42 · HTTExon1 · Axonal 
transport · Secretion
Introduction
It is now generally accepted that the prion-like behavior 
of some aggregation prone proteins is associated with the 
spread of pathology observed in several neurodegenerative 
diseases. For Parkinson disease (PD), early evidence came 
from the startling observation that Lewy bodies, which are 
in part comprised of α-synuclein (α-syn) fibrils, were pre-
sent in fetal nigral neurons which had been grafted into the 
brain of PD patients several years before as a therapeutic 
measure [24, 26]. This surprising finding suggested that 
α-syn aggregates may propagate from the host diseased 
tissue into the graft tissue [10]. The idea of the spread of 
α-syn pathology within the CNS is strongly supported by a 
series of recent studies in mice in which stereotaxic deliv-
ery of fibrillar α-syn caused the spread of α-syn deposits 
to anatomically connected brain regions, away from the 
injection site [28, 29, 36]. Critically, injection of fibrils into 
Abstract Accruing evidence suggests that prion-like 
behavior of fibrillar forms of α-synuclein, β-amyloid pep-
tide and mutant huntingtin are responsible for the spread 
of the lesions that characterize Parkinson disease, Alz-
heimer disease and Huntington disease, respectively. It is 
unknown whether these distinct protein assemblies are 
transported within and between neurons by similar or dis-
tinct mechanisms. It is also unclear if neuronal death or 
injury is required for neuron-to-neuron transfer. To address 
these questions, we used mouse primary cortical neurons 
grown in microfluidic devices to measure the amounts of 
α-synuclein, Aβ42 and HTTExon1 fibrils transported by 
axons in both directions (anterograde and retrograde), as 
well as to examine the mechanism of their release from 
axons after anterograde transport. We observed that the 
three fibrils were transported in both anterograde and ret-
rograde directions but with strikingly different efficiencies. 
The amount of Aβ42 fibrils transported was ten times higher 
than that of the other two fibrils. HTTExon1 was efficiently 
transported in the retrograde direction but only marginally 
in the anterograde direction. Finally, using neurons from 
two distinct mutant mouse strains whose axons are highly 
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α-syn knockout mice caused no pathology, indicating that 
spread was dependent on templating by endogenous α-syn 
[28]. Besides α-syn and PD, prion-like spreading may con-
tribute to other neurodegenerative diseases [39]. Similar 
studies have revealed that proteins associated with Alzhei-
mer disease (AD) and Huntington disease (HD) can also 
propagate within the nervous system. For AD, there is com-
pelling evidence for the transmissibility of tau pathology 
in vitro and in vivo [9, 13, 23, 55]. Beta-amyloid, the major 
component of amyloid plaques in AD, has been shown to 
propagate in mice even after intraperitoneal injection [15]. 
For Huntington disease (HD), mutant huntingtin (mHTT) 
has been observed in neuronal grafts in patients, an obser-
vation similar to that made for α-syn in PD, although in 
this case the deposits were extracellular [8]. Furthermore, 
mHTT fibrils can spread between neurons in various 
in vitro culture systems [35, 40].
Early in disease, the lesions of PD, AD and HD are 
restricted to specific CNS structures. However, with time 
they spread to more distant, interconnected areas suggest-
ing a role for axonal transport. This is the basis for Braak’s 
model of PD, which posits that an uncharacterized “agent” 
spreads in time in a stereotypical manner between areas 
connected by anterograde or retrograde axonal projections 
and induces the formation of Lewy bodies [5, 6]. It now 
appears that the hypothetical “agent” could be misfolded 
assemblies of α-syn itself. Using primary neurons cultured 
in microfluidic devices we previously showed that the fibril-
lar form of α-syn was transported in axons in both antero-
grade and retrograde directions with kinetics characteristic 
of the slow component b of axonal transport. Furthermore, 
after anterograde transport we observed the internaliza-
tion of the transported fibrils by second order neurons [18], 
observations congruent with the Braak model. To date, lit-
tle is known about the neuronal transport of other disease-
implicated proteins such as Aβ42 and HTTExon1 under 
similar experimental conditions. Spread by axonal trans-
port also raises the question of the mechanism of transport 
and of exit from axons. In particular, is axon degeneration 
and lysis required for exit, or are fibrils actively secreted by 
relatively healthy neurons? Such unanswered questions are 
central to our understanding of the pathogenesis of these 
neurodegenerative diseases. To address them we devised an 
assay that measures the amount of fibrils transported under 
well-defined conditions, in both anterograde and retrograde 
directions, and we used the assay to compare the axonal 
transport of α-syn, Aβ42 peptide and HTTExon1. We 
observed large differences in the transport of the different 
fibrils. We used two different mouse mutants to determine 
if lysis was required for their exit from axons. We observed 
that in all cases exit from axons was independent of lysis, 
consistent with an active secretion process, which may be 
amenable to therapeutic modulation.
Materials and methods
α‑Syn, Aβ42, HTTExon1, Ure2p and Sup35p
The expression and purification of human wild-type α-syn 
was performed as previously described [19]. α-Syn fibril 
formation was induced by incubation in 50 mM Tris–HCl, 
pH 7.5, 150 mM KCl buffer at 37 °C under continuous 
shaking in an Eppendorf Thermomixer set at 600 r.p.m. 
The expression and purification of human HTTExon1 
with a 48 glutamine stretch was performed as previously 
described [32]. HTTExon1 was assembled in 20 mM 
Tris–HCl, pH 7.5, 150 mM KCl, 5 mM MgCl2, 1 mM 
ATP, 100 mM imidazole and 10 % glycerol, at 37 °C with-
out shaking for 24 h. The expression and purification of 
Met-Aβ 1–42 was performed as described [53]. Aβ 1–42 
was assembled in DMEM, at 37 °C without shaking for 
24 h.
α-Syn, Aβ42 and HTTExon1 fibrils were centrifuged 
twice at 15,000g for 10 min, resuspended twice in PBS. 
The fibrils were labeled with Alexa-555 (Life Technology, 
# A-20009) NHS fluorophore following the manufacturer’s 
instructions using a protein:dye ratio of 1:2. The labeling 
reactions were arrested by addition of 1 mM Tris pH 7.5. 
The unreacted fluorophore was removed by a final cycle of 
two centrifugations at 15,000g for 10 min and resuspen-
sions of the pelleted fibrils in PBS. The amount of Alexa-
555 incorporated was assessed by mass spectrometry. The 
samples were de-salted with 5 % acetonitrile, 0.1 % Trif-
luoroacetic acid (TFA) and eluted from a C18 reversed-
phase Zip-Tip (Millipore, Billerica, MA, USA) in 50 % 
acetonitrile, 0.1 % TFA. Peptide samples were mixed in a 
ratio of 1:5–1:20 (v⁄v) with sinapinic acid (10 mg/mL) in 
50 % acetonitrile and 0.1 % TFA and spotted (0.5 µL) on a 
stainless steel MALDI target (Opti-TOF; Applied BioSys-
tems). MALDI-TOF-TOF MS spectra were acquired with 
a MALDI-TOF⁄TOF 5800 mass spectrometer (Applied 
Biosystems) using linear mode acquisition. External cali-
bration was performed using unmodified α-syn, Aβ42 and 
HTTExon1. Acquisition and data analysis were performed 
using the Data Explorer software from Applied Biosys-
tems. The MALDI-TOF mass spectra of Alexa-555-labeled 
α-syn, Aβ42 and HTTExon1 are shown in Fig. 1a (from 
left to right). The spectra show that the fractions of labeled 
α-syn, Aβ42 and HTTExon1 are 60, 20 and 25 %, respec-
tively with, on average, one Alexa-555 per 1, 5 and 4 mol-
ecules of α-syn, Aβ42 and HTTExon1, respectively. The 
nature of the assemblies was assessed using a JEOL 1400 
transmission electron microscope following adsorption 
onto carbon-coated 200-mesh grids and negative staining 
with 1 % uranyl acetate. The images were recorded with a 
Gatan Orius CCD camera (Gatan). Representative electron 
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micrographs of fibrillar α-syn, Aβ42 and HTTExon1 are 
shown in Fig. 1b (from left to right).
Recombinant Ure2p, and hexa-histidine tagged Sup35p 
were expressed in E. coli strain BL21-CodonPlus and puri-
fied as described previously [25, 46]. The two yeast pri-
ons were assembled into fibrils at 6 °C under gentle agi-
tation (<100 rpm) in 50 mM Tris–HCl, pH 8.0, 200 mM 
NaCl, 5 % glycerol, 5 mM β-mercaptoethanol, 10 mM 
MgCl2, 2 mM EGTA for Sup35p, 20 mM Tris–HCl pH 7.5, 
200 mM KCl, 1 mM EGTA, 1 mM DTT for Ure2p. The 
assembly reactions were monitored by thioflavin-T bind-
ing and transmission electron microscopy observation. The 
fibrils were labeled with Alexa-555 NHS fluorophore after 
sedimentation and resuspension in PBS and the unreacted 
dye was eliminated as described above for α-syn, Aβ42 and 
HTTExon1 fibrils. Calibration curves (Fig. 1c) were con-
structed to determine the amount of fibrils by fluorescence 
spectroscopy using a Quantamaster QM-4/2000 spectro-
fluorometer equipped with an UXL-75XE short arc lamp 
(Ushio Inc. Japan). Excitation and emission wavelengths 
were 550 and 565 nm, respectively. The excitation and 
emission slits were set at 2 and 6 nm, respectively.
Primary neuron cultures
C57BL/6 wild type and C57BL/6Sarm1 knock out mutant 
mice were obtained form Jackson. The C57BL/6WldS 
mutant line was a gift from BA Barres (Stanford University 
Medical School). Primary cortical neurons prepared from 
E-17 mouse embryos were grown in microfluidic devices 
(Xona SND 450) for 1 week as described previously [18]. 
In these devices, anterograde transport can be studied when 
fluorescent fibrils are added to the soma/dendrite channel 
Fig. 1  Characterization of α-syn, Aβ42 and HTTExon1 fibrils. a 
MALDI-TOF mass spectra of, from left to right, Alexa-555 labeled 
α-synuclein (MH+ 14458.7), Alexa-555 labeled Aβ42 (MH+ 
4644.7) and Alexa-555 labeled HTTExon1 (MH + 14,373.8). The 
number of Alexa 555 molecules covalently bound is indicated. b 
Electron micrographs of the fibrillar forms of α-synuclein, Aβ42 
and HTTExon1 used throughout this study. The scale bar represents 
200 nm. c Calibration curves for Alexa-555 labeled α-synuclein, 
Alexa-555 labeled Aβ42 and Alexa-555 labeled HTTExon1 within 
the concentration rang of 1 pM–20 µM
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and retrograde transport when fibrils are added to the axon 
channel.
Fluorescent fibril measurements
To measure the amount of fibrils transported in the antero-
grade direction, Alexa 555-labeled fibrils were added to the 
soma channel at a final concentration of 1 µM. The fibril 
suspension was sonicated for 20 min at 4 °C in a Branson 
bath sonicator just prior to being added to the culture. The 
culture was incubated for 24 h. An excess medium vol-
ume of 50 µl was maintained in the axon wells and chan-
nel during incubation. The medium in the axon wells and 
channel was harvested after 24 h. The axons were lysed by 
adding 60 µl of a mixture of detergent (0.1 % SDS, 1 % 
TritonX100, 0.5 % sodium deoxycholate) to the wells and 
channel. The lysate was collected and the wells and chan-
nel were rinsed once with 60 µl of the detergent mixture. 
The fluorescence of the medium and lysate was measured 
with a Quantamaster QM-4/2000 spectrofluorometer (Pho-
ton Technology International, Inc., Lawrenceville, NJ) set 
at 550 nm (excitation) and 565 nm (emission). The amount 
of fluorescent protein was determined using calibration 
curves established for each type of pure fibrils for concen-
trations ranging form 1 pM to 20 µM (Fig. 1c). The same 
procedure was used to measure the amount of fibrils trans-
ported in the retrograde direction except that in this case 
fibrils were added to the axon wells and channel.
Western blot analysis
The proteins present in the medium of the microfluidic 
devices were denatured by incubation at 95 °C for 5 min in 
50 mM Tris–HCl, pH 6.8, 4 % SDS, 2 % beta-mercaptoe-
thanol, 12 % glycerol and 0.01 % bromophenol blue, sepa-
rated in a 10 % polyacrylamide gel and probed with anti 
α-syn antibody (1:5000, BD Biosciences, 610787). In our 
hands fibrillar α-syn fully disassembles into monomers in 
sample buffer and runs as a single band with a molecular 
weight of 14 kDa [36].
Internalization of fibrils
The technique was described previously [43]. Briefly, pri-
mary cultures of neurons (5 × 104 neurons per well) were 
prepared in 8 well LabTek chamber slides (Nunc). After 
1 week of culture, Alexa488 labeled fibrils were added at 
a final concentration of 1 µM. Internalization was meas-
ured at 1, 3, 5, 7 h after the addition of fibrils. At each time 
point, the medium was removed, the cells were washed 3 
times with PBS. Trypan blue (0.1 % in PBS) was added to 
each well and the cells were observed using a phase con-
trast/fluorescence microscopic set up with a 20× objective. 
Pictures of 15–20 tiled frames were taken and stored for 
further analysis. Control wells without fibrils were used to 
ensure the absence of background fluorescence. The per-
centage of neuron containing fluorescent puncta was deter-
mined manually by counting more than 100 neurons for 
each well.
Immunostaining
Cells were fixed with 4 % paraformaldehyde in PBS for 
30 min at room temperature, followed by 4 washes with 
PBS. For SMI-31 and SMI-32 immunostaining, antigen 
retrieval was performed with the Retrieve-All3 Buffer 
(Covance, SIG-31904-500) at 95 °C for 10 min, followed 
by 4 washes with PBS. Incubation with the primary SMI-
31 and SMI-32 antibodies (1/1000) was done in 3 % BSA, 
0.1 % TritonX100 in PBS, overnight at 4 °C. Following 
washes in PBS the secondary antibody (a goat anti-mouse 
Ig coupled to Alexa 488 fluorochrome (ThermoFisher)) 
was incubated for 1 h at room temperature, using the same 
buffer. For the EEA1 (CST, 3288), Rab5 (CST, 3547), 
Rab7 (CST, 9367), Lamp1 (DSHB, 1D4B), BIII-tubulin 
(Synaptic systems, 303 304), MAP2 (Synaptic systems 
188 004) and a-syn (Abcam, ab138501) immunostainings, 
primary antibodies were diluted in 5 % goat serum, 0.3 % 
TritonX100 in PBS and incubated on fixed cells overnight 
at 4 °C. Alexa Dye-conjugated goat anti-rat, -rabbit and 
-guinea pig antibodies were used as secondary antibodies 
(ThermoFisher).
Reagents
The microfluidic devices were from Xona (SND 450). 
SMI-31, SMI-32 monoclonal antibodies were from Cov-
ance. EEA1, Rab5, Rab7 monoclonal antibodies were pur-
chased from Cell signaling technology (CST), Lamp1 from 
DSCB, BIII-tubulin and MAP2 from Synaptic systems. 
Alexa Dye-conjugated goat secondary antibodies were 
from ThermoFisher.
Results
Comparing anterograde and retrograde transport 
of α‑syn, A‑β42 and HTTExon1 fibrils
Microfluidic devices, which physically separate neuron 
cell bodies from their axons, are ideally suited to study 
both the anterograde and retrograde transport of fibrils 
by axons [47]. We previously used this technique to char-
acterize the transport of α-syn fibrils in axons of primary 
embryonic mouse neurons [18]. In the present work we 
extended these observations to fibrillar forms of the Aβ42 
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peptide and HTTExon1 to determine if these distinct pro-
tein assemblies would be transported by similar or different 
mechanisms (Fig. 1). For studies of anterograde transport, 
we added fluorescently labeled fibrils to the channels with 
neuronal soma and measured the fluorescence released in 
the axon channels after 24 h (Fig. 2a–d). To measure ret-
rograde transport, we added the labeled fibrils to the axon 
channels and measured the amount transported to the soma 
channels (Fig. 2e–h). For both anterograde and retrograde 
transport, we measured the fluorescence of the medium 
as well as the fluorescence released after lysis of cellular 
structures with detergents. Fluorescence of medium repre-
sented proteins spontaneously released in the medium after 
transport. Fluorescence of the lysate represented fibrils pre-
sent in axons or soma/dendrites after anterograde and ret-
rograde transport, respectively. We used calibration curves 
(see “Materials and methods”, Fig. 1c) to determine the 
number of picomoles of monomeric proteins transported 
from the fluorescence values. We used fluorescent cholera 
toxin subunit B (CTB) to estimate the number of axons 
per microfluidic device (Supp. Figure 2, Table 1). When 
added to axon termini, CTB binds to plasma membranes, 
is internalized and diffuses into the entire neuron arbores-
cence (Supp. Figure 2). Part of it migrates to the perinu-
clear region of the Golgi cisternae [3, 17]. Since CTB is 
not released from the cells in which it has been internal-
ized, only soma whose axons entered the microgrooves are 
labeled (Table 1). In Table 2, the results of transport of each 
fibril are displayed as the number of femtomoles of mono-
meric protein transported per axon in 24 h.
Fig. 2  Axonal transport of fibrils in microfluidic devices. Quantity 
(p.moles) of fibrillar α-syn, Aβ42 and HTTExon1 transported by 
axons in 24 h in the anterograde and retrograde directions. Primary 
embryonic cortical neurons were grown in microfluidic devices. 
Fibrils (1 µM monomer) were added to the soma or axon compart-
ments. Fluorescence was measured in the opposite compartment after 
24 h of incubation. a–d Anterograde transport. e–h Retrograde trans-
port. a, e Schematics of the experimental design. Fibrils are depicted 
as coin piles. b–h Ordinates give the number of picomoles of fibrils 
transported per microfluidic device in 24 h. Note that the ordinate 
values are different for the three kinds of fibrils but that, for a given 
fibril, they are the same for anterograde and retrograde transport. M 
fibrils spontaneously released in the medium. L fibrils released after 
lysis by detergents of the axons or soma for, respectively the antero-
grade and the retrograde transport. n number of microfluidic devices 
used for the measurement
Table 1  Number of axons in microfluidic devices
Alexa 488-labeled CTB (5 ng/µl) was added to the axon channel of 
7 day-old neuron cultures. After 24 h the cultures were fixed with 4 % 
paraformaldehyde. The soma channel was scanned with a fluores-
cence microscope equipped with a ×40 lens. The CTB positive soma 
were counted. In some experiments, Alexa 555-labeled α-syn fibrils 
(10 µM) were mixed with CTB and the number of CTB and α-syn 
positive soma was determined. n.d. No fibrils were added in these 
experiments
Experiment nb. CTB + soma α-Syn + soma % axons  
transporting
α-syn
1 290 166 57 %
2 253 133 53 %
3 294 170 58 %
4 190 n.d. –
5 258 n.d. –
6 178 n.d. –
7 281 n.d. –
8 235 n.d. –
9 242 149 62 %
10 278 64 23 %
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Consistent with our previous findings, α-syn, was 
transported in both anterograde and retrograde directions 
(Fig. 2b, f, Supp. Figure 1b, e, Table 2). Aβ42 peptides 
were also transported in both directions but strikingly the 
amount of protein that appeared in axons after anterograde 
transport and in soma/dendrites after retrograde trans-
port was more than ten times higher than that observed 
with α-syn fibrils (Fig. 2c, g, Supp. Figure 1c, f, Table 2). 
HTTExon1 fibrils were not significantly transported in 
the anterograde direction but retrograde transport pro-
ceeded similarly to that of α-syn fibrils (Fig. 2d, h, Supp. 
Figure 1g, Table 2). The ratio of anterograde versus retro-
grade transport was lower for HTTExon1 fibrils than for 
the other two (0.2 for HTTExon1 fibrils versus 0.7 and 
0.6 for α-syn and Aβ42 fibrils, respectively). Interestingly 
the majority of HTTExon1 fibrils remain intracellular 
after retrograde transport, whereas approximately 50 % of 
α-syn and Aβ42 fibrils were released into the medium.
After retrograde transport, the signal given by fluores-
cently labeled α-syn overlapped that obtained by immu-
nostaining with an anti-α-syn antibody (Supp. Figure 3a, 
b), suggesting that the internalized and transported α-syn 
was not degraded during the course of these experiments. 
Additionally, we observed that part of the internalized and 
retrogradely transported fluorescently labeled fibrils over-
lapped with late endosomal and lysosomal markers, in par-
ticular Rab7 and Lamp1 but not early endosomal marker 
EEA1 or Rab5 (Supp. Figure 4 and Supp. Figure 5). Fur-
thermore, the majority of fibrils transported in the antero-
grade direction (85 %) were released from the axons into 
the medium (Table 2) and the released α-syn was intact, un-
degraded protein (Supp. Figure 3c).
Since internalization, the first step in the transport of 
fibrils, could be rate limiting, we compared the rate of fibril 
internalization by primary cortical neurons. We measured the 
fraction of neurons that internalized fibrils as a function of 
time of incubation (Fig. 3a–c). The values were similar for 
α-syn, Aβ42 and HTTExon1 and we observed that by 5 h 
approximately 60 % of all neurons had internalized fibrils 
added to the culture medium. The number of fluorophores 
per molecule and the molecular weight of the protein (which 
determines the number of subunit per fibril of a given size) 
are comparable for Aβ42 and HTT40 (see “Materials and 
methods”). Therefore, Fig. 3 suggests that the number of 
fibrils internalized as a function of time is similar for both. 
Nonetheless, the amount of fibrils transported and released 
in the medium is considerably higher for Aβ42.
The transport of fibrillar forms of yeast prions Sup35p 
and Ure2p
Our results provide evidence that the transport of fibrillar 
proteins by neurons depends greatly on the nature of the 
protein. To explore this further, we next analyzed trans-
port of fibrillar forms of 2 yeast prions, Sup35p and Ure2p, 
which both form fibrils that can be internalized by mamma-
lian cells. Both yeast prions were transported in amounts 
and patterns (anterograde versus retrograde transport) simi-
lar to HTTExon1 fibrils and different from those of α-syn 
and Aβ42 fibrils (Fig. 4a, b). These data provide further 
evidence that axonal transport is strongly dependent on the 
nature of the fibrillar protein. It also indicates that the trans-
port of fibrils by neurons does not require the presence of 
an endogenous homologous protein.
Table 2  Amount of fibrils (femtomoles) transported in the antero-
grade and retrograde direction in 24 h
Sample α-Syn A-β 42 HTT Exon1
Anterograde, medium 10.4 111.2 7.6
Anterograde, lysate 2.4 16.0 0.8
Anterograde, total 12.8 127.2 8.4
Retrograde, medium 9.6 120.8 7.6
Retrograde, lysate 8.4 106.4 28.4
Retrograde, total 18.0 227.2 36.0
Antero./retro. 0.71 0.56 0.23
% released in medium  
after anterograde transport
81 % 87 % 90 %
Fig. 3  Internalization of fibrils by neuron soma. Primary embryonic 
cortical neurons were grown in 8 well LabTek slides at low density. 
Alexa488-labeled fibrils (1 µM monomer) were added and incubated 
for 1, 3, 5, and 7 h. At each time point the fibrils were removed; the 
cells were washed with PBS; 0.1 % Trypan Blue in PBS was added 
and pictures (phase contrast and fluorescence) of tiled fields of the 
cultures were recorded. a Quantification of the  % of neurons that 
internalized fibrils was determined for a minimum of 150 neurons. 
Four independent experiments were performed. b, c Representative 
bright field and fluorescent images of primary cortical neurons 5 h 
after exposure to α-syn fibrils or control medium
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The release of fibrils from axons
It has been proposed that fibril toxicity is responsible for 
neuron death in neurodegenerative diseases [37, 52]. There-
fore, we wondered whether the release of the proteins under 
study in the medium after anterograde transport could be the 
result of neuronal injury and axon lysis. To test this hypoth-
esis, we performed experiments with neurons whose axons 
are intrinsically resistant to degeneration. We used neurons 
from two mouse mutants, the spontaneous WldS mutant and 
the Sarm1 knockout. Axons from these mutants are remark-
ably resistant to injury, remaining structurally and function-
ally intact in the mouse, weeks after nerve transection and in 
culture weeks after axotomy [11, 31, 34, 54]. We reasoned 
that if the proteins were released from axons owing to axon 
lysis, the WldS and Sarm1−/− mutations should reduce the 
amount of released fibrils. If, on the other hand, fibrils were 
released by an active process, independent of axon lysis, 
the amount of fibrils released from these mutant neurons 
should not differ from the amount released by WT neurons. 
We isolated neurons from WT, WldS and Sarm1−/− mice, all 
with the same C57Bl/6 background. We first confirmed that 
mutant axons remained intact after 24 h of incubation with 
fibrils, using SMI-31 and SMI-32 monoclonal antibodies, 
which are specific for phosphorylated and unphosphorylated 
neurofilaments, respectively (Fig. 5e, f). Next, we meas-
ured the release of α-syn, Aβ42 or Htt exon 1 proteins in 
the medium following anterograde axonal transport. For the 
three proteins, the amount of protein released was not sta-
tistically different for WT and mutant neurons (Fig. 5a–c). 
This result indicates the three different fibrils were secreted 
by axons in the absence of axonal lysis.
Discussion
The work of Braak and his collaborators indicates that the 
lesions of PD and AD spread in time along both antero-
grade and retrograde axonal projections [5, 6, 48]. The 
ability of fibrillar α-syn to be internalized by neurons and 
to promote the fibrillization of endogenous α-syn, has 
been documented [4, 12, 21, 30, 33]. Together these results 
form the basis for a model in which the prion-like prop-
erties of α-syn fibrils and their axonal transport might be 
responsible for the progression of PD pathology. In a previ-
ous publication, we reconstructed two steps of this model 
using primary cortical mouse neurons grown in microflu-
idic devices. We showed that the α-syn fibrils were trans-
ported in axons in both the anterograde and the retrograde 
direction and that, after anterograde transport some of them 
were internalized by a second order neuron [18]. In the 
present work we quantified the axonal transport of fluores-
cently labeled α-syn fibrils by measuring the fluorescence 
delivered to the receiving compartment of the microfluidic 
device. Using calibration curves that relate fluorescence to 
concentration and using CTB to determine the number of 
axons, we measured the number of α-syn molecules trans-
ported in 24 h per axon in both the anterograde and retro-
grade direction (Fig. 2b, f; Table 2). On average an axon 
transported 12.5 femtomoles of α-syn in 24 h in the anter-
ograde direction. Interestingly, in the case of retrograde 
transport, we determined that only about 55 % of the axons 
transported fibrils (Table 1). As a result, each of these 
axons transported approximately 40 femtomoles of α-syn 
in 24 h. Since primary cultures of cortical neurons are a 
heterogeneous population, the fact that only half of them 
transported fibrils may indicate the existence of specifici-
ties according to the origin of the neuron, which, if true, 
could have relevance to pathogenesis.
We compared the transport of fibrils of α-syn, Aβ42 and 
HTTExon1, and observed large differences. The most strik-
ing one was with Aβ42 fibrils, which were transported in 
approximately ten times higher amounts than α-syn and 
HTTExon1 fibrils. The large amount of fibrils that accumu-
late in the soma after retrograde transport raises the issue of 
their intra-cytoplasmic localization. Using 3-color immu-
nofluorescence and confocal microscopy, we showed that 
most of of them co-localize with the endosome/lysosome 
markers Rab7 and Lamp1. This holds true for α-syn Aβ42 
and HHTExon1 (Supp. Figure 3). It may indicate that the 
endosome/lysosome pathway is involved in the secretion 
of these proteins after their retrograde transport. Interest-
ingly, there is good evidence that although Aβ42 oligom-
ers interfere with fast axonal transport of organelles [14, 
22, 46] fibrillar Aβ42 does not [38], an observation that is 
consistent with our results. Also, evidence is mounting that 
the intraneuronal accumulation of fibrillar Aβ42 could play 
an important role in AD pathology [20, 45]. Therefore, the 
efficient axonal transport of Aβ42 fibrils and their accumu-
lation in soma after retrograde transport could be important 
factors in the pathogenesis of AD. The ratio of anterograde 
to retrograde transport also varied widely between the 
Fig. 4  Transport of the fibrillar forms of Ure2p and Sup35p yeast 
prions by mouse neurons. The experiment was performed as for 
α-syn, Aβ42 and HTTExon1 fibrils (Fig. 2). Ure2p fibrils were 
obtained as described [49]. Sup35p fibrils were obtained as described 
[25]
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fibrils, with HTTExon1 fibrils being transported mainly in 
the retrograde direction. Overall, our results show that steps 
such as internalization, cytoplasmic addressing to the axon 
or transport per se, are performed by neurons with very dif-
ferent efficiencies depending on the nature of the fibrils. 
We examined the part that internalization may play in these 
differences. As shown in Fig. 3a, Aβ42 and HTTExon1 
were internalized at similar rates although they were trans-
ported with very different yields. A combination of phys-
ico-chemical properties of fibrils, such as size, stiffness, 
surface charge and hydrophobicity may determine steps 
in axonal transport subsequent to internalization. Fibrils 
comprised of the same protein can adopt distinct conforma-
tions which may contribute to distinct clinical features [1, 
27, 36]. These strain specific conformations of fibrils could 
alter their axonal transport.
We showed previously that the kinetics of anterograde 
axonal transport of α-syn fibrils corresponds to that of slow 
component b [18]. Slow component b transports a large 
variety of axonal proteins, including α-syn, from their cyto-
plasmic site of synthesis to their delivery sites along the 
axon. These proteins are transported in large assemblies, 
which are not enclosed in a membrane [41, 42, 44]. The 
molecular link that attaches the assemblies to the kinesin 
motors has not been identified. We hypothesize that fibril-
lar α-syn, Aβ42 and HTTExon1 may share surface prop-
erties, and possibly size, with slow component b protein 
assemblies, that could serve to introduce them in this path-
way of axonal transport.
An important aspect of the present work is the demon-
stration that the proteins under study were secreted from 
axons after anterograde transport (Fig. 2a–d). This is con-
sistent with recently published results obtained in a mouse 
model [51]. Secretion of α-syn, including its fibrillar form, 
in exosomes has been suggested by the work of others [2, 
7, 16, 50]. Exosomes may fuse with the plasma membrane 
of a target neuron, delivering fibrils in the cytoplasm where 
it could seed the misfolding of endogenous α-syn. Continu-
ous secretion of α-syn fibrils by axons may contribute to 
the spread of lesions in the CNS of PD patients. It is now 
important to understand the molecular details of the trans-
fer of fibrils from axons to a second order neuron to devise 
specific therapies to halt the progression of neurodegenera-
tive diseases such as PD.
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Fig. 5  Quantity of α-syn, Aβ42 and HTTExon1 released in the 
medium in 24 h of anterograde transport by axons from C57BL/6wt 
(WT), C57BL/6WldS (Wlds/s) and C57BL/6Sarm1−/− (Sarm1−/−) 
mice. Primary embryonic cortical neurons from mice of the 3 geno-
types were grown in microfluidic devices. Fibrils were added to the 
soma compartments. The fluorescence of the medium in the axon 
compartments was measured after 24 h of incubation. n number of 
microfluidic devices used for the measurement. n.s Not statisti-
cally significant. d, e Staining with the SMI-31 and SMI-32 mono-
clonal antibodies of the soma and axon of WldS neurons in micro-
fluidic devices after 24 h of transport of α-syn fibrils. Similar results 
were obtained with WT and Sarm1−/− neurons and with Aβ42 and 
HTTExon1 fibrils. SMI-32 did not detect un-phosphorylated neuro-
filaments, a sign of axonal damage. A positive control for the SMI-
32 antibody was obtained by treating the soma with staurosporin to 
induce apoptosis (not shown)
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